通过虚拟节点增强药物分子全局特征,提升靶点亲和力预测精度
ViDTA: Enhanced Drug-Target Affinity Prediction via Virtual Graph Nodes and Attention-based Feature Fusion
- 引入虚拟节点扩展图神经网络的感知范围,融合局部与全局分子结构信息
- 在Davis、Metz、KIBA数据集上优于现有方法,显著提升预测性能
- 适合药物发现、分子对接等领域的研究者使用
药物-靶点相互作用是理解药物如何影响生物系统的基础,准确预测药物-靶点亲和力(DTA)对药物发现至关重要。近年来,深度学习方法已成为估算药物与靶蛋白结合强度的重要手段。然而,现有方法仅利用药物分子拓扑结构的局部信息,缺乏全局信息;同时,药物与蛋白质特征通常采用简单拼接方式融合,限制了其表达效果。为此,我们提出ViDTA,一种增强型DTA预测框架。在基于图神经网络(GNN)的药物特征提取网络中引入虚拟节点,作为全局记忆单元,实现更高效的跨节点信息传递。通过虚拟节点,无缝整合药物分子的局部与全局特征,扩大GNN的感受野。此外,我们设计了一种基于注意力的线性特征融合网络,以更好捕捉药物与蛋白质间的交互信息。在Davis、Metz和KIBA等多个基准数据集上的实验结果表明,所提出的ViDTA优于当前最先进的基线模型。
原文摘要 · Abstract (English)
Drug-target interaction is fundamental in understanding how drugs affect biological systems, and accurately predicting drug-target affinity (DTA) is vital for drug discovery. Recently, deep learning methods have emerged as a significant approach for estimating the binding strength between drugs and target proteins. However, existing methods simply utilize the drug's local information from molecular topology rather than global information. Additionally, the features of drugs and proteins are usually fused with a simple concatenation operation, limiting their effectiveness. To address these challenges, we proposed ViDTA, an enhanced DTA prediction framework. We introduce virtual nodes into the Graph Neural Network (GNN)-based drug feature extraction network, which acts as a global memory to exchange messages more efficiently. By incorporating virtual graph nodes, we seamlessly integrate local and global features of drug molecular structures, expanding the GNN's receptive field. Additionally, we propose an attention-based linear feature fusion network for better capturing the interaction information between drugs and proteins. Experimental results evaluated on various benchmarks including Davis, Metz, and KIBA demonstrate that our proposed ViDTA outperforms the state-of-the-art baselines.
Thank you to arXiv for use of its open access interoperability. PaperDance 不是 arXiv 官方产品;中文卡片由大模型生成,请以原文为准。